21 Jan
2021

Why 2021 will be a pivotal year for life sciences patents in China

Radical reforms to China’s IP system are set to benefit pharma and biotech patentees, but several key questions remain unanswered

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth